Skip to content

AARDVARK THERAPEUTICS, INC.

AARD

CIK 0001774857

← back to feed
Revenue (TTM)
$0
Q1 Apr 2026
Net Income (TTM)
−$61.58M
−179.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$3.11
+43.1% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$54.27M
Q1 Apr 2026
Cash
$62.44M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
21.82M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings